<DOC>
	<DOCNO>NCT01230866</DOCNO>
	<brief_summary>The purpose study compare effect ( good bad ) patient prostate cancer compare standard dose radiation therapy ( 44 treatment 8Â½-9 week ) high daily dose radiation ( 5 treatment 1-2 week ) see effect treatment similar well .</brief_summary>
	<brief_title>Study Hypo-fractionated Proton Radiation Low Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically confirm prostate adenocarcinoma within 365 day prior randomization . History/physical examination digital rectal examination prostate baseline toxicity assessment within 90 day prior randomization . Histological evaluation prostate biopsy assignment Gleason score biopsy material ; Gleason score must range 26 . &gt; 6 core strongly recommend . PSA value &lt; 10 ng/ml within 90 day prior randomization . Either do prior biopsy least 21 day prostate biopsy . Clinical stage T1aT2a N0 M0 ( AJCC Criteria 7th Ed. ) . Staging must do treat investigator . No pelvic lymph node &gt; 1.5 cm great dimension unless enlarge lymph node biopsied negative . Patients must least 18 year old . ECOG performance status 01 ( appendix I ) document within 90 day prior randomization . IPSS score &lt; 16 . Patients must give IRB approve , study specific , informed consent . Patients must complete mandatory test list section 4.0 within specify time frame . Patients must able start treatment within 56 day randomization . Previous prostate cancer surgery include : prostatectomy , hyperthermia cryosurgery . Previous pelvic radiation prostate cancer . Androgen deprivation therapy prior radiation allow . However , acceptable continue radiation adjuvant therapy . Active rectal diverticulitis , Crohn 's disease affect rectum , ulcerative colitis . Prior systemic chemotherapy prostate cancer . History proximal urethral stricture require dilatation . Current continue anticoagulation warfarin sodium ( Coumadin , heparin , lowmolecular weight heparin , Clopidogrel bisulfate ( Plavix ) , equivalent . ( Unless stop manage treatment related toxicity , biopsy need , marker placement ) . Any major medical , addictive psychiatric illness would affect consent process , completion treatment and/or interfere followup . Consent legal authorize representative permit study . Evidence cancer within past 5 year &lt; 50 % probability 5 year survival . ( Prior concurrent diagnosis basal cell noninvasive squamous cell cancer skin allow ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Proton Radiation Prostate Cancer</keyword>
</DOC>